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Abstract
Changes possibly induced by 3-NP in electrophysiological functional characteristics of the central nervous system are, in contrast to
biochemical and morphological alterations, less well known. In this study, the usability of a standard neurophysiological investigation system
to detect functional changes caused by 3-NP administration in rats was studied. In subacute treatment, 10 or 15 mg/kg 3-NP was given i.p. on
five consecutive days to groups of 10 rats and the effects were checked 4 weeks later. Acutely treated rats received 20 mg/kg i.p. after several
control records. For recording, the animals’ left hemisphere was exposed in urethane anesthesia. Silver electrodes were placed on the cortical
sensory foci and tungsten needles in the subcortical (caudatum, globus pallidus) recording sites. Spontaneous electrical activity, as well as
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domatosensory, visual and auditory evoked potentials, were recorded. Following subacute treatment, the slowest (theta) and fastest (beta2
nd gamma) frequencies of the spontaneous activity were changed, differently in the cortical versus subcortical sites. In the sensory evoked
otentials after subacute treatment, an increase of the latency was seen in all sensory areas. In the acutely treated animals, the amplitude of
he somatosensory evoked potential decreased after giving 3-NP. With double stimuli, the relation of the two responses was treatment- and
nterval-dependent. Understanding the mechanism of these effects may widen the knowledge base for using 3-NP in disease models.
2005 Elsevier B.V. All rights reserved.
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. Introduction
The ‘natural’ origin of most of our food by far does not
ean that they cannot contain toxic substances. The com-
ound 3-nitropropionic acid (3-NP) is naturally found in As-
ragalus species (Leguminosae; Johnson et al., 2000), and
ccasionally causes severe or fatal poisoning in grazing farm
nimals (James et al., 1980). Human intoxication may result
rom infestation of foodstuffs (sugar cane, cereals, etc.) with
oulds of the Anthirium and Aspergillus genus (Scallet et
l., 2001; Patocka et al., 2000; Peraica and Domijan, 2001),
roducing 3-NP.
Human exposure to 3-NP, even in low doses, causes acute
ncephalopathy followed by dystonia (Liu et al., 1992). Tor-
ion spasms and jerky movements were observed in the vic-
ims, and CT images indicated lesions of the basal ganglia
He et al., 1995).
∗ Corresponding author. Tel.: +36 62 545 119; fax: +36 62 545 120.
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The morphological and functional effects of 3-NP intox-
ication have been replicated in animal experiments. With
a dose similar to ours (5× 20 mg/kg i.p.), Teunissen et al.
(2001) obtained decrease of motor performance in rats. Tis-
sue degeneration, involving primarily the striatum but also
the hippocampus and thalamus, was also described, both in
vitro (Behrens et al., 1995) and in vivo (following one dose
of 10–30 mg/kg 3-NP; McCracken et al., 2001), and was in-
terpreted as a morphological correlate of the motor disorders.
Based on that, 3-NP has been introduced in modeling Hunt-
ington’s disease in animals (Brouillet et al., 1999).
At the cellular level, 3-NP inhibits succinate dehydroge-
nase, a key enzyme of oxidative energy production (Coles
et al., 1979). The effect develops fast and is not limited to
the sites of morphological damage (Brouillet et al., 1998). In
mouse hippocampus, e.g., population spike amplitude was
diminished by repeated doses of 20 mg/kg 3-NP, apparently
due to inhibition of oxidative phosphorylation (Hellweg et
al., 2003). 3-NP was also found to act on synaptic transmis-
sion by influencing NMDA receptors. The resulting excess in382-6689/$ – see front matter © 2005 Elsevier B.V. All rights reserved.
oi:10.1016/j.etap.2004.12.062
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glutamatergic excitation led to chemically induced long-term
potentiation in in vitro slices (Calabresi et al., 2001) and to
excitotoxicity both in vitro and in vivo (Pubill et al., 2001).
Although, a general mitochondrial impairment in the brain
and the disturbance of glutamatergic transmission is likely to
be reflected also in e.g. the spontaneous and stimulus-evoked
cortical activity, and the description of such effects would
be required to a comprehensive description of the chronic
disease models based on 3-NP, no data of this kind were found
in the literature. The aim of this work was therefore to see
to what extent the neurophysiological investigation system
established in our laboratory is suitable to detect functional
changes caused by 3-NP administration in rats.
2. Methods
The effects of 3-NP were investigated in three different
time schemes—it is known from Brouillet et al. (1999) that
dosing schemes and time until recording can have a major in-
fluence on the effects of 3-NP. In the subacute experiments,
adult male Wistar rats (of 450–500 g body weight, 10 an-
imals per treatment group) received 10 (low dose) and 15
(high dose) mg/kg b.w. 3-NP i.p. for five consecutive days
and were kept for further 4 weeks before recording. Control
a
t
w
w
s
T
t
r
t
s
t
s
n
(
1
t
t
a
K
e
a
d
e
p
o
a
o
r
t
latency and duration of the evoked responses was measured
manually.
In previous studies with other neurotoxicants (Papp et al.,
2000a,b) it was found that changes in the measurable parame-
ters of cortical responses evoked with multiple stimulation are
sensitive to the toxic influence. In the present study, double-
pulse somatosensory stimulation was used (repetition time,
1 s; inter-stimulus time, 60–300 ms). From the double-pulse
records, the second:first ratio for amplitude and latency was
calculated and interpreted as measure of dynamic interaction
between the two excitation processes. It was tested whether
this interaction is sensitive to the toxic influence.
The results of subacute and acute (24 h) exposure were
tested for significance with one-way ANOVA. For the results
of immediate treatment (pre- and post-application data), re-
peated measure ANOVA was used. Post hoc analysis was
done by LSD with p< 0.05 as limit.
During the whole study, the principles of the Ethical Com-
mittee for the Protection of Animals in Research of the Uni-
versity were strictly followed.
3. Results
3.1. Effects on the spontaneous cortical activity
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tnimals were untreated. For acute exposure, 10 animals (of
he same strain and weight) received 20 mg/kg 3-NP i.p. and
ere kept for 24 h. To see immediate effects, further 10 rats
ere first prepared for recording and four of the recording
equences described below were taken with 20 min interval.
hen, 20 mg/kg 3-NP i.p. was given and further 6–8 records
aken. For comparison, the intraperitoneal LD50 of 3-NP in
ats is 67 mg/kg (Pass et al., 1985).
For recording, the animals were anaesthetized with ure-
hane (1000 mg/kg i.p.) and were placed in a stereotaxic in-
trument. The left hemisphere was exposed and silver elec-
rodes were placed on the dura over the primary somatosen-
ory (SS), visual (VIS) and auditory (AUD) areas. One steel
eedle electrode each was inserted in the caudato-putamen
stereotaxic coordinates: AP 0, L 3, V 5; Paxinos and Watson,
982) and the globus pallidus (AP 2, L 3, V 6).
The recording sequence started with spontaneous elec-
rical activity (electrocorticogram, ECoG), recorded from
hese sites simultaneously for 6 min from the record, the rel-
tive spectral power of the frequency bands (delta to gamma;
andel and Schwartz, 1985) was determined. Then, stimulus-
voked activity was recorded from the mentioned cortical
reas. Somatosensory stimulation was done by a pair of nee-
les inserted into the whiskery skin, delivering rectangular
lectric stimuli of 3–4 V and 0.2 ms. Visual stimulation was
erformed by flashes (60 lx) from a flash generator via an
ptical fiber directed into the contralateral eye of the rat. For
coustic stimulation, clicks (40 dB) were applied into the ear
f the rat. Of each modality, one series of 50 stimuli at 1 s
epetition time (1 Hz frequency) was applied to each rat, and
he evoked activity was recorded. After averaging, amplitude,In subacute exposure, the most conspicuous effect was the
ignificant (SS: F2,27 = 16.59, p< 0.001; VIS: F2,27 = 5.48,
< 0.014; AUD: F2,27 = 9.62, p< 0.001) decrease in the theta
ctivity seen in all cortical foci in the high-dose animals
Fig. 1A–C). In the other bands, the changes were not uni-
orm: increase of the delta activity was significant only in the
S and VIS area, decrease of alpha in the VIS area, and in-
rease of beta2 in the SS and AUD areas. In the basal ganglia
Fig. 1D, E) activity decreased in the slow, delta and theta
ands (significant in the high-dose group and only in the
audatum, delta: F2,27 = 5.51, p< 0.015; theta: F2,27 = 2.94,
< 0.05). Increase of the gamma band activity was seen in
he caudatum and the globus pallidus, but was significant only
n the latter (F2,27 = 3.33, p< 0.05). In the low-dose rats, the
hanges were mostly below significance.
In the rats recorded 24 h after 3-NP application (Fig. 2),
he trend of the ECoG bands was partly similar to that ob-
ained by subacute exposure. In the SS area (Fig. 2A), delta
ctivity increased significantly (F1,18 = 4.17, p< 0.054). The
ncrease of theta and decrease of faster bands was not sig-
ificant. In the VIS focus (Fig. 2B) the changes were sim-
lar but only the decrease of alpha activity was significant
F1,18 = 4.49, p< 0.046). In the AUD cortex (Fig. 2C) delta
ctivity increased significantly (F1,18 = 13.43, p< 0.001), and
lpha, beta1 and beta2, decreased (alpha: F1,18 = 20.66,
< 0.001; beta1: F1,18 = 10.10, p< 0.004; beta2: F1,18 = 4.02,
< 0.051).
The ECoG changes observed within ca. 2 h after i.p. ap-
lication of 20 mg/kg 3-NP are shown in Fig. 3. None of
he changes was significant but it was clearly visible that
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Fig. 1. Effects of 3-NP on the spontaneous cortical (A, somatosensory; B,
visual; C, auditory area) and subcortical (D, caudato-putamen; E, globus
pallidus) activity in subacute exposure (control, untreated; low dose: 10, high
dose: 15 mg/kg 3-NP i.p. on five consecutive days; recording in 4 weeks).
Ordinate: relative power of the standard frequency bands in control and
treated animals (means, n= 10). Inset: frequency bands. *p< 0.05 vs. control
in the same band.
Fig. 2. Effects of 3-NP on the spontaneous cortical activity (A, somatosen-
sory; B, visual; C, auditory area) in acute exposure (20 mg/kg 3-NP i.p.,
recording in 24 h), displayed as in Fig. 1. *p< 0.05 vs. control in the same
band.
the change at 100 min was to the same direction as 4 weeks
or 24 h after 3-NP administration. The time course of the
alterations was, however, such that the immediate change
(10 min after administration) was opposite to that seen at
100 min.
3.2. Effects on cortical evoked potentials
The general slow-down of the cortical activity following
subacute treatment with 3-NP was paralleled by the increased
latency of the sensory evoked potentials (Fig. 4). The change
was significant in all recorded cortical areas and in both
treated groups versus control (SS: F2,27 = 7.19, p< 0.004;
VIS:F2,27 = 16.82, p< 0.001; AUD:F2,27 = 10.72, p< 0.001).
The change seemed to be dose-dependent but high versus
low dose differences were not significant. The alteration of
the duration of the responses was slight. In acute (24 h) 3-
NP exposure (Fig. 5), there was no consequent effect on the
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Fig. 3. Immediate effect of 3-NP (20 mg/kg i.p.) on the spontaneous corti-
cal activity (A, somatosensory; B, visual; C, auditory area). Abscissa: time
elapsed after drug administration, con is the average of pre-administration
records. Other features as in Fig. 1.
latency: small decrease in the SS and AUD response but
significant increase (F1,18 = 4.44, p< 0.049) in the VIS re-
sponse. The duration of the potentials was, on the contrary,
significantly increased in the SS (F1,18 = 4.54, p< 0.046),
and VIS (F1,18 = 4.66, p< 0.031) but not in the AUD
area.
3.3. 3-NP effects on the dynamic interaction in the
somatosensory system revealed by double-pulse
stimulation
Double-pulse somatosensory stimulation with different
inter-stimulus intervals was used to investigate dynamic inter-
action in the sensory system. It was supposed that the relative
refractory state left behind by the first cortical response would
detectably alter the measured parameters of the second one.
In rats recorded 24 h after 20 mg/kg 3-NP i.p., the second:first
ratio of the SS cortical response was less than 0.5, that is, the
second response was considerably suppressed by the first one
Fig. 4. Effects of 3-NP on the cortical evoked potentials (A, somatosensory;
B, visual; C, auditory area) in subacute exposure (low dose: 10, high dose:
15 mg/kg 3-NP i.p. on five consecutive days; recording in 4 weeks). Abscissa:
latency (lat.) and duration (dur.) of the potentials. Ordinate: mean + S.D.
(n= 10) of the respective value. Inset: doses. **p< 0.01 vs. control.
(Fig. 6A) but the effect was practically the same in untreated
control rats. The second:first ratio of latency values was dif-
ferent in the treated and control rats, but not significantly and
with no clear dependence on the inter-stimulus interval.
In rats injected with 3-NP during recording (immediate ef-
fect), the second:first ratio of the amplitude changed in depen-
dence of the time elapsed and of the inter-stimulus interval. As
seen in Fig. 6B, the ratio in the control period (−60 to 0) fluc-
tuated around 0.5. After i.p. administration of 20 mg/kg 3-NP,
the ratio started to increase (that is, the second response was
less impeded by the first one) and went well over 1. For 300
and 240 ms inter-stimulus interval, the increasing trend was
present from ca. the 80th minute on and by the end of record-
ing it was significant (treatment effect, 300 ms: F1,18 = 4.53,
p< 0.038; 240 ms: F1,18 = 4.62, p< 0.027; treatment–time in-
teraction also significant). The increase started only later for
180 ms interval, and for 120 ms, it was negligible. The la-
tency ratio in the same rats was influenced by 3-NP only
ca. 100 min after injection (Fig. 6C). The change was de-
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Fig. 5. Effects of 3-NP on the cortical evoked potentials (A, somatosensory;
B, visual; C, auditory area) in acute exposure (20 mg/kg 3-NP i.p., recording
in 24 h), displayed as in Fig. 4. *p< 0.05 vs. control.
pendent on the inter-stimulus interval but remained below
significance.
4. Discussion
The 3-NP induced several alterations in the spontaneous
and evoked cortical electrical activity of treated rats. The prin-
cipal way of action of 3-NP is to cause energy insufficiency
in the neurons by impeding mitochondrial oxidation (Coles
et al., 1979), resulting in a tissue hypoxia-like state. In hu-
man volunteers, breathing low-oxygen gas mixture caused
an EEG shift to lower frequencies (van der Post et al., 2002).
Also, in human cases of inherited or idiopathic mitochondrial
dysfunction, like mitochondrial encephalomyopathy (ME),
cortical functions were affected (Montirosso et al., 2002).
The EEG abnormalities seen were interpreted as a sensitive
indicator of brain mitochondrial disorder (Smith and Hard
Fig. 6. (A) denote the effect of 3-NP in acutely treated rats (20 mg/kg i.p.,
recorded in 24 h) on the second:first ratio of amplitude (diamonds) and first
peak latency (squares) of the somatosensory evoked potential elicited with
double stimuli (see Section 2). Abscissa: inter-stimulus time. Ordinate: sec-
ond:first ratio (mean, n= 10). Inset: control and treated. (B) and (C) denotes
time course of the amplitude and first peak latency, respectively, of the so-
matosensory evoked potentials obtained by double stimuli, in rats before
and immediately after i.p. application of 20 mg/kg 3-NP. Abscissa: time (3-
NP was given at 0 ms). Ordinate: second:first ratio (mean, n= 10) of the
parameters. Inset in (B): inter-stimulus time for (B) and (C). *p< 0.05 vs.
pre-administration period.
ing, 1993). The main EEG abnormality of ME patients was
slowed activity (Sciacco et al., 2001), which was similar to the
ECoG alteration (increased slow – delta and theta – activity in
all cortical foci) obtained in our work by subchronic 3-NP ad-
ministration. In earlier works of our laboratory, it was found
that various environmental neurotoxicants (pesticide agents,
heavy metals) induce a shift in the ECoG power spectrum
(Institoris et al., 2002; Schulz et al., 1997). Regarding that
the EEG (or ECoG) signals result from the spatio-temporal
summation of a high number of individual neuronal activities
(Kandel and Schwartz, 1985) the non-specific nature of the
EEG alteration, stressed by Smith and Harding (1993) is un-
derstandable. The fact that the ECoG alteration was similar
when recorded 4 weeks after the last application (subacute
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treatment) or 24 h after a single application (acute treatment)
suggested that a rapidly developing mechanism of 3-NP ac-
tion was involved—most probably energetic impairment as
suggested also by the similarity of this effect to that seen in hy-
poxic persons or ME patients. Brain cholinesterase, another
enzyme affected by 3-NP (Ludolph et al., 1991) has most
probably no role in the ECoG changes as the frequency shift
is opposite to that obtained by organophosphates (De´si and
Nagymajte´nyi, 1999) which are established cholinesterase
inhibitors.
Further it can be supposed that the ECoG changes, caused
by energetic impairment or other mechanism, are not likely
to run in parallel with the morphological and functional alter-
ations (Brouillet et al., 1999) serving as the base of modelling
Huntington’s disease by applying 3-NP.
In the subacutely treated rats, the effect of 3-NP on
cortical-evoked potentials was similar to what had been de-
scribed from ME patients. In particular, the alteration of cer-
tain visual-evoked potential components in ME (Finsterer,
2001; Scaioli et al., 1998) and the increase of evoked poten-
tial latency in the treated rats was similar. The changes in the
measured parameters of the cortical evoked responses in the
treated rats were dissimilar in subacute versus acute 3-NP
treatment, possibly indicating another mechanism of action
besides (or instead of) mitochondrial impairment. A known
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